Full Abstracts for the symposium now available
The complete text of abstracts submitted to the 2024 San Antonio Breast Cancer Symposium® are now available on the Abstracts page of this website. Head over to access the document for review and download.
Don't miss out, register today!
There are less than three weeks until the start of the 47th annual San Antonio Breast Cancer Symposium® on December 10, 2024. You won't want to miss this important opportunity to join nearly 11,000 researchers, clinicians, patient advocates, and supporters from around the world who are working to shape the future of breast cancer research and care.
Two important portals for presenters
SABCS 2024 is almost here and we have now launched the Presenter Submission Portal, allowing presenters to upload their presentations, audio files and posters. At the same time, the Abstract Submission Portal is still important. It’s where presenters can submit their financial disclosure information, view their co-authors, and make any necessary updates to biographical information. Be sure and log in to both portals as you are finishing up your presentation preparation.
Last-minute hotel opportunities
The deadline for booking housing through SABCS® has passed, but we have worked with a handful of hotels to continue to make discount rooms available for SABCS® attendees. If you haven't booked your stay through SABCS® and our vendor, Orchid Events, do it now while the opportunity still exists.
AACR awards announced for 2024
The winners of two prestigious awards have just been announced by the San Antonio Breast Cancer Symposium and the American Association for Cancer Research.
Steffi Oesterreich, PhD, is the recipient of the 2024 AACR Distinguished Lectureship in Breast Cancer Research, supported by Aflac, Inc. This award was established to recognize outstanding science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.
Oesterreich’s award lecture will be presented on Thursday, December 12, at 3 p.m. CT in the Stars at Night Ballroom 1-2 in the Henry B. Gonzalez Convention Center.
Christina Curtis, PhD, MSc, is the recipient of the 2024 AACR Outstanding Investigator Award for Breast Cancer Research, supported by the Breast Cancer Research Foundation. This award was established to honor an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.
Curtis’ award lecture will be presented on Wednesday, December 11, at 3 p.m. CST in the Stars at Night Ballroom 1-2 at the convention center.
Full Program online now
The program has been updated with all sessions, titles and presenters for every day during the four days of SABCS® 2024. Titles and presenters are now on the program for every presentation, general session, Rapid Fire mini-oral session, and Poster Spotlight session. The schedule for the nearly 2,000 posters that will be presented during the week are available for download on PDF.
Affiliate Meetings deadline extended to December 2
More than 300 Affiliate Meetings are already scheduled during SABCS 2024. Now the deadline to apply to add your meeting has been extended to Monday, December 2. Head over to our Satellite Symposia and Affiliate Meetings web page to see times meetings can be held, read guidelines, and submit your application.
Product Theater schedule released
Prominent industry leaders such as Novartis, Lilly, and Pfizer Oncology are scheduled to hold Product Theater sessions at the 2024 San Antonio Breast Cancer Symposium. The full schedule of theater presentations has just been released. These sessions are a great opportunity for SABCS attendees to get insights into the latest breakthroughs, clinical trials, and emerging therapies directly from the companies developing them. There are 11 Product Theater presentations spread across Wednesday, Thursday, and Friday during the symposium.
Nobel Laureate to give Keynote Address at SABCS® 2024
William G. Kaelin Jr., MD, winner of the 2019 Nobel Prize in Physiology or Medicine, will deliver the Keynote Address at the 2024 San Antonio Breast Cancer Symposium®. Kaelin is Sidney Farber Professor of Medicine at Harvard University and runs the Kaelin Lab for Cancer Biology at the Dana-Farber Cancer Institute in Boston. His groundbreaking work in cancer biology and his pioneering research into the role of oxygen-sensing pathways in cancer cells have made him a leading figure in cancer research. Dr. Kaelin's presentation, "(Re)emerging Principles for Controlling Cancer with Drugs," will start at 8:35 a.m. CST on Wednesday, December 11, in Hall 1 of the Henry B. Gonzalez Convention Center in San Antonio.
Laura J. van 't Veer named 2024 McGuire Award winner
Laura J. van 't Veer, PhD, will receive the William L. McGuire Lecture Award during the 2024 San Antonio Breast Cancer Symposium®. She is scheduled to deliver her lecture on Wednesday morning, December 11. Van ’t Veer is professor and Angela and Shu Kai Chan Endowed Chair in Cancer Research in the Department of Laboratory Medicine at the University of California, San Francisco (UCSF). She is also the director of applied genomics and leader of the Breast Oncology Program for the UCSF Helen Diller Family Comprehensive Cancer Center.
SABCS® 2024 Presenter Guidelines and templates now available
Guidelines for presenters are now available on the SABCS 2024 website. You can find information if you are a General Session Oral Presenter, a Rapid Fire Mini-Oral presenter, a Poster Spotlight presenter or a Poster Session presenter. Click the links below for more information.
General Session Oral Presentation Guidelines
Rapid Fire Presentation Guidelines
Poster Spotlight Guidelines
Poster Presenter Guidelines
SABCS® Meeting News
Get the latest news and updates about the sessions and science coming to SABCS® 2024.
Child Care
Onsite child care will be available during the Symposium for children ages 6 months to 12 years. Learn more about the care and the times the care will be available on our Onsite Services web page.